Summit Global Investments Supernus Pharmaceuticals, Inc. Transaction History

Summit Global Investments

  • $1.57 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023
BUY
$34.93 - $42.03 $545,920 - $656,886
15,629 Added 84.94%
34,029 $1.23 Million
Q4 2022

Jan 31, 2023
BUY
$31.09 - $37.88 $3,109 - $3,788
100 Added 0.55%
18,400 $656,000
Q3 2022

Nov 14, 2022
SELL
$28.79 - $35.41 $495,188 - $609,051
-17,200 Reduced 48.45%
18,300 $619,000
Q2 2022

Aug 23, 2022
BUY
$25.33 - $34.25 $899,214 - $1.22 Million
35,500 New
35,500 $1.03 Million

Others Institutions Holding SUPN

# of Institutions
283
Shares Held
60.6M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $2.11B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Summit Global Investments Portfolio

Follow Summit Global Investments and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

News

Stay updated on Summit Global Investments with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email